LFST
HealthcareLifeStance Health Group, Inc. · Medical - Care Facilities · $3B
What is LifeStance Health Group, Inc.?
LifeStance Health Group is a leading outpatient mental health services provider operating across 32 U.S. states. The company delivers care both in-person and virtually, making behavioral health more accessible to a broad patient population.
LifeStance connects patients with licensed clinicians through a hybrid model — combining physical clinic locations with a telehealth platform. Revenue is generated primarily through insurance reimbursements for outpatient mental health visits. The company serves children, adolescents, adults, and geriatric patients, treating conditions ranging from anxiety and depression to bipolar disorder and PTSD. Its scale across dozens of states gives it a broad geographic footprint uncommon among pure-play behavioral health providers.
LifeStance Health was founded in 2017 and is headquartered in Scottsdale, Arizona.
- Psychiatric evaluations and medication management
- Individual, family, and group therapy sessions
- Psychological and neuropsychological testing
- Virtual telehealth mental health platform
- In-person care at multi-state clinic network
Is LFST a Good Stock to Buy?
UQS Score rates LFST as Below Average overall, reflecting meaningful structural challenges alongside a notably strong growth profile.
The Growth pillar stands out as a clear bright spot, reflecting the company's rapid expansion across states and rising patient volume in a structurally underpenetrated market. The Risk pillar also registers as Good, suggesting the business is not exposed to extreme financial or operational hazards relative to peers.
Both the Quality and Moat pillars score Weak, pointing to thin profitability characteristics and limited durable competitive advantages — concerns that weigh on the overall composite rating.
Pro members can view the exact pillar breakdown and full financial metrics behind the LFST rating at UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does LFST pay dividends?
No — LifeStance Health Group, Inc. does not currently pay a dividend.
LFST does not currently pay a dividend. As a growth-stage healthcare company still scaling its clinic network and telehealth platform, LifeStance reinvests available capital into expansion rather than returning cash to shareholders. Investors focused on income should look elsewhere; those with a growth orientation may find the reinvestment rationale more aligned with their goals.
When does LFST report earnings?
LifeStance Health reports earnings on a quarterly cadence, consistent with standard practice for U.S.-listed equities.
The company has shown meaningful revenue growth in recent periods, driven by clinician headcount expansion and increased visit volumes. Profitability, however, remains a work in progress — a recurring theme for growth-oriented healthcare platforms at this stage of development.
For the most recent quarter's results and guidance, visit LifeStance Health's investor relations page directly.
What if I invested in LifeStance Health Group, Inc.?
Based on LifeStance Health Group, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
LFST Long-term Outlook
The fundamental outlook for LFST is shaped by two competing forces: a strong growth trajectory in an underserved market, and persistent questions around unit economics and competitive differentiation. The behavioral health sector continues to see rising demand, which supports the top-line growth story. However, the Weak Quality and Moat scores suggest the path to durable, high-quality earnings is not yet clear. Valuation sits at Neutral, meaning the market appears to be pricing in the growth opportunity without obvious excess or discount.
Growth drivers
- Structural demand growth for outpatient mental health services across the U.S.
- Continued geographic expansion into new states and markets
- Hybrid telehealth model enabling higher clinician utilization and patient reach
Key risks
- Weak moat leaves the business exposed to competition from well-funded entrants
- Insurance reimbursement rate pressure could compress already thin margins
- Scaling a clinician workforce is operationally complex and cost-intensive
LFST vs Peers
LFST operates in a fragmented behavioral and post-acute healthcare landscape alongside several publicly traded peers with distinct business models.
Extendicare focuses on long-term care and home health services in Canada, serving a largely geriatric population rather than the broad outpatient mental health market LFST targets.
NHC operates skilled nursing and assisted living facilities, making it a more traditional post-acute care provider compared to LifeStance's outpatient behavioral health focus.
Acadia is the closest direct peer, operating inpatient and residential behavioral health facilities — a higher-acuity model than LifeStance's outpatient and telehealth approach.
Frequently Asked Questions
What does LifeStance Health do?
LifeStance Health provides outpatient mental health services through a network of clinics and a telehealth platform spanning 32 U.S. states. Services include psychiatric evaluations, therapy, and neuropsychological testing for patients of all ages, from children to seniors.
Does LFST pay dividends?
No, LFST does not pay a dividend. The company is in a growth phase and reinvests capital into expanding its clinic network and telehealth capabilities rather than distributing cash to shareholders.
When does LFST report earnings?
LifeStance Health reports earnings quarterly, in line with standard U.S. public company practice. For specific dates and the most recent results, check the investor relations section of the company's official website.
Is LFST a good stock to buy?
UQS Score rates LFST as Below Average overall. While the Growth pillar is Strong and Risk registers as Good, the Weak Quality and Moat scores reflect real structural concerns. Whether it fits your portfolio depends on your risk tolerance and investment goals — the full breakdown is available to Pro members.
Is LFST overvalued?
The UQS Valuation pillar for LFST is rated Neutral, suggesting the market is pricing the stock in line with its fundamental profile — neither obviously cheap nor clearly stretched. Investors should weigh this against the Weak Quality and Moat scores when forming a view.
How does LFST compare to its competitors?
LFST is a pure-play outpatient behavioral health provider, which sets it apart from peers like Acadia Healthcare, which focuses on inpatient facilities, and NHC, which operates skilled nursing homes. Its hybrid in-person and telehealth model is relatively differentiated within the behavioral health space.
What is LFST's market cap bracket?
LFST is classified as a mid-cap stock. This places it in a range where institutional coverage exists but the company still carries more growth-stage characteristics than large or mega-cap healthcare peers.
Who founded LifeStance Health?
LifeStance Health was founded in 2017. Founding and leadership details are publicly available through the company's official website and SEC filings for those seeking background on the executive team.
Is LFST a long-term quality investment?
As a long-term quality indicator, the UQS composite score for LFST is Below Average, driven by Weak scores in Quality and Moat. The Strong Growth pillar is encouraging, but durable long-term quality typically requires stronger profitability and competitive advantages than LFST currently demonstrates.
What is the main competitive advantage of LifeStance Health?
LifeStance's scale — operating across 32 states with both physical clinics and a telehealth platform — provides a breadth of access that smaller regional providers cannot easily replicate. However, the UQS Moat pillar rates this advantage as Weak, reflecting the competitive intensity of the behavioral health market.
What sector does LFST belong to?
LFST operates in the Healthcare sector, specifically within outpatient behavioral and mental health services. It sits at the intersection of traditional clinical care and digital health, given its telehealth delivery model.
Is LFST a growth stock or value stock?
Based on UQS pillar labels, LFST leans firmly toward the growth category — the Growth pillar is rated Strong while Valuation is Neutral. It is not priced as a deep-value opportunity, and its investment case rests primarily on continued expansion in the behavioral health market.
Unlock Full LFST Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View exact UQS pillar scores across all five dimensions
- ✓Access full financial metrics and trend data
- ✓Compare LFST against sector peers side by side
- ✓See the complete Quality and Moat breakdown
- ✓Get Growth and Risk detail behind the rating
- ✓Pro members unlock the complete analyst view
Pro Analysis
LFST — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 46.1 | 25.6 | 22.0 | 82.2 | 68.0 | 50.1 | +0.3 |
| May 16, 2026 | 45.8 | 25.1 | 22.0 | 82.2 | 68.0 | 49.3 | +0.8 |
| May 7, 2026 | 45.0 | 21.4 | 22.0 | 81.3 | 71.0 | 47.9 | +0.1 |
| May 3, 2026 | 44.9 | 21.4 | 22.0 | 81.3 | 71.0 | 47.4 | -0.2 |
| Apr 26, 2026 | 45.1 | 21.4 | 22.0 | 81.3 | 71.0 | 48.6 | 0.0 |
| Apr 19, 2026 | 45.1 | 21.4 | 22.0 | 81.3 | 71.0 | 49.0 | -0.4 |
| Apr 18, 2026 | 45.5 | 22.3 | 22.0 | 81.3 | 71.0 | 50.3 | -1.9 |
| Apr 14, 2026 | 47.4 | 22.3 | 22.0 | 81.3 | 71.0 | 62.8 | 0.0 |
| Apr 12, 2026 | 47.4 | 22.3 | 22.0 | 81.3 | 71.0 | 63.0 | -0.1 |
| Apr 11, 2026 | 47.5 | 22.3 | 22.0 | 81.3 | 71.0 | 63.3 | +0.1 |
LFST — Pillar Breakdown
Quality
— 25.6/100 (25%)LifeStance Health Group, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 82.2/100 (20%)LifeStance Health Group, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 68.0/100 (15%)LifeStance Health Group, Inc. maintains a reasonable risk profile with manageable debt levels.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 50.1/100 (15%)LifeStance Health Group, Inc. has a mixed valuation — some metrics suggest fair value while others appear stretched.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 22/100 (25%)LifeStance Health Group, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for LFST.
Score Composition
Financial Data
More Stock Analysis
How is the LFST UQS Score Calculated?
The UQS (Unified Quality Score) for LifeStance Health Group, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses LifeStance Health Group, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether LifeStance Health Group, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.